Nav: Home

How tissues harm themselves during wound healing

March 25, 2020

Osaka, Japan - Most tissues of the body have the extraordinary ability to heal themselves upon injury. But sometimes something goes awry during the complex process of wound healing and the tissue forms too much connective tissue, also called fibrosis, around the injured area, which can result in the organ not functioning properly. Now, researchers from Osaka University have identified a novel protein that plays a central role in the development of such excess scar tissue. In a new study published in Immunity, they showed how the protein Rbm7 induces cell death after tissue injury to then result in the recruitment of a specific type of immune cells, which initiate the formation of tissue fibrosis.

While the reasons for tissue injury can be manifold, including infections, trauma and drug side effects, the default response of the tissue is quite the same in all these cases: Forming new tissue to heal and replace the injured tissue. This seemingly straightforward task includes a complex interplay between tissue and immune cells. While a plethora of molecular actors have been described to participate in this crosstalk, a clear understanding of how tissue fibrosis develops and how it could be prevented has been lacking.

"Fibrosis is a serious phenomenon that irrevocably worsens tissue function," says corresponding author of the study Shizuo Akira. "The goal of our study was to further our mechanistic understanding of fibrosis and discover a potential new avenue for medical treatment of tissue fibrosis."

To achieve their goal, the researchers induced lung fibrosis in mice using bleomycin, a chemotherapeutic drug known to cause lung fibrosis. They first found that the production of the Rbm7, a protein with largely unknown function, is increased in the fibrotic lungs. The researchers then investigated clinical specimens from patients with lung fibrosis and found that Rbm7 is also present in larger quantities in humans with lung fibrosis.

"What made the discovery of Rbm7 so intriguing is the fact that mice lacking Rbm7 produced much less lung fibrosis," says lead author of the study Kiyoharu Fukushima. "We wanted to know the molecular basis for the pro-fibrotic actions of Rbm7."

The researchers showed that an interaction between damaged tissue cells and a specific type of immune cells, so called segregated-nucleus-containing atypical monocytes (SatMs), is key to the onset of fibrosis. When tissue is damaged, by for example the drug bleomycin, affected tissue cells ramp up the production of Rbm7, whose downstream actions eventually result in the death of these cells. As a result, molecules that recruit SatMs are released, which then irreversibly replace the damaged area by scar tissue.

"These are striking results that show how a single protein has the ability to cause something as detrimental as fibrosis," says Akira. "Our findings could offer a new opportunity to prevent and treat tissue fibrosis by targeting Rbm7."
-end-
The article, "Dysregulated expression of the nuclear exosome targeting complex component RBM7 in nonhematopoietic cells licenses the development of fibrosis," was published in Immunity at DOI: https://doi.org/10.1016/j.immuni.2020.02.007

About Osaka University

Osaka University was founded in 1931 as one of the seven imperial universities of Japan and now has expanded to one of Japan's leading comprehensive universities. The University has now embarked on open research revolution from a position as Japan's most innovative university and among the most innovative institutions in the world according to Reuters 2015 Top 100 Innovative Universities and the Nature Index Innovation 2017. The university's ability to innovate from the stage of fundamental research through the creation of useful technology with economic impact stems from its broad disciplinary spectrum.

Website: https://resou.osaka-u.ac.jp/en/top

Osaka University

Related Immune Cells Articles:

Mapping immune cells in brain tumors
It is not always possible to completely remove malignant brain tumors by surgery so that further treatment is necessary.
Nutrient deficiency in tumor cells attracts cells that suppress the immune system
A study led by IDIBELL researchers and published this week in the American journal PNAS shows that, by depriving tumor cells of glucose, they release a large number of signaling molecules.
Experience matters for immune cells
The discovery that immune T cells have a spectrum of responsiveness could shed light on how our immune system responds to infections and cancer, and what goes wrong in immune diseases.
Immune cells against Alzheimer's?
German researchers have developed a novel, experimental approach against Alzheimer's.
Arming the body's immune cells
Researchers at UC have discovered a previously unknown mechanism that could explain the reason behind decreased immune function in cancer patients and could be a new therapeutic target for immunotherapy for those with head and neck cancers.
Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.
How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.
How the immune system becomes blind to cancer cells
Researchers have described the activation of a key protein used by tumor cells to stop the body's immune response.
What protects killer immune cells from harming themselves?
White blood cells, which release a toxic potion of proteins to kill cancerous and virus-infected cells, are protected from any harm by the physical properties of their cell envelopes, find scientists from UCL and the Peter MacCallum Cancer Centre in Melbourne.
How self-reactive immune cells are allowed to develop
A research team at Lund University in Sweden has found the mechanism that controls the growth of B1-cells in mice.
More Immune Cells News and Immune Cells Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Meditations on Loneliness
Original broadcast date: April 24, 2020. We're a social species now living in isolation. But loneliness was a problem well before this era of social distancing. This hour, TED speakers explore how we can live and make peace with loneliness. Guests on the show include author and illustrator Jonny Sun, psychologist Susan Pinker, architect Grace Kim, and writer Suleika Jaouad.
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.